Actively Recruiting

Phase 1
Phase 2
Age: 18Years +
All Genders
NCT06024824

Dose-Painted Intensity Modulated Radiotherapy Pancreas (DP-IMRT Pancreas)

Led by Cancer Trials Ireland · Updated on 2025-07-20

49

Participants Needed

2

Research Sites

387 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a prospective non-randomised Phase I/II Radiotherapy (RT) study with patients recruited to escalated dose cohorts. Patients with resectable or borderline resectable (per the National Comprehensive Cancer Network (NCCN) criteria) pancreatic adenocarcinoma will receive dose-escalated hypofractionated DP-IMRT via Intensity Modulated Radiotherapy (IMRT) / Volume Modulated Arc Therapy (VMAT).

CONDITIONS

Official Title

Dose-Painted Intensity Modulated Radiotherapy Pancreas (DP-IMRT Pancreas)

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Written informed consent obtained prior to any study-related procedures
  • Age 18 years or older
  • ECOG performance status 0 to 2
  • Resectable or borderline resectable pancreatic adenocarcinoma per NCCN criteria
  • Histologically confirmed pancreatic ductal adenocarcinoma with staging cT1N0-2, cT2N0-2, or cT3N0-2 planned for pre-operative chemo-radiotherapy
  • Imaging with CT thorax, abdomen, and pelvis plus MRI abdomen confirms no metastatic disease
  • Females of child-bearing potential must not be pregnant or lactating and agree to use contraception; males with partners of child-bearing potential must use contraception
Not Eligible

You will not qualify if you...

  • Previous thoracic, abdominal, or pelvic radiation therapy
  • Prior treatment for bilirubin regression other than stenting
  • Known co-existing or prior malignancy within the last 5 years (except basal cell or squamous cell carcinoma of the skin) likely to interfere with treatment or outcome assessment
  • Syndromes or conditions that increase radiosensitivity
  • Uncontrolled illness or psychiatric/social conditions limiting compliance
  • Any other significant clinical or laboratory condition making participation undesirable or limiting protocol compliance due to psychological, familial, sociological, or geographical reasons

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

St Luke's Radiation Oncology Network (SLRON)

Dublin, Ireland

Actively Recruiting

2

St Vincent's University Hospital

Dublin, Ireland

Actively Recruiting

Loading map...

Research Team

C

Cancer Trials Ireland

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Dose-Painted Intensity Modulated Radiotherapy Pancreas (DP-IMRT Pancreas) | DecenTrialz